• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Clinical profiles and one-year outcome in middle eastern patients with atrial fibrillation and major bleeding events. The Jordan atrial fibrillation study
Background and Aims: Oral anticoagulant agents (OACs) reduce the risk of stroke and systemic embolism (SE) in patients with atrial fibrillation (AF) but may increase the risk of major bleeding (MB) events. There is a scarcity of studies that address the incidence, predictors, and outcomes of bleeding events in AF patients in the Middle East. This contemporary multicenter study sought to evaluate in detail the bleeding events and predictors of these events
Source: Atherosclerosis - August 1, 2023 Category: Cardiology Authors: A. Hammoudeh, Y. Khader, Y. Badaineh, R. Tabbalat, S. Rawashdeh, M. Jammal, S. Abrumman, I. Alhaddad Source Type: research

One-Year Clinical Outcome in Middle Eastern Patients with Atrial Fibrillation: The Jordan Atrial Fibrillation (JoFib) Study
CONCLUSIONS: This study of Middle Eastern AF patients has reported high adherence to OACs. The use of OACs was associated with a lower risk for all-cause mortality. One-year rates of stroke and major bleeding events were comparable to those reported from other regions in the world.PMID:35462945 | PMC:PMC9020983 | DOI:10.1155/2022/4240999
Source: International Journal of Vascular Medicine - April 25, 2022 Category: Cardiology Authors: Ayman Hammoudeh Yousef Khader Ramzi Tabbalat Yahya Badaineh Nazih Kadri Haneen Shawer Eyas Al-Mousa Rasheed Ibdah Batool A Shawer Imad A Alhaddad Source Type: research

Pages: 1  2  3